Encompass Health Corp (AMEX:EHC) – SunTrust Banks cut their Q2 2019 EPS estimates for Encompass Health in a research note issued to investors on Monday, April 29th, according to Zacks Investment Research. SunTrust Banks analyst D. Macdonald now expects that the company will post earnings of $0.96 per share for the quarter, down from their previous forecast of $0.99. SunTrust Banks also issued estimates for Encompass Health’s Q3 2019 earnings at $0.93 EPS, Q4 2019 earnings at $0.89 EPS and FY2019 earnings at $3.82 EPS.
Separately, Zacks Investment Research lowered Encompass Health from a “hold” rating to a “sell” rating in a report on Monday, April 15th. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $79.00.
Encompass Health (AMEX:EHC) last announced its quarterly earnings results on Thursday, April 25th. The company reported $1.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.15. The firm had revenue of $1.12 billion during the quarter, compared to the consensus estimate of $1.12 billion. The firm’s revenue was up 7.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.93 EPS.
Hedge funds have recently bought and sold shares of the company. Mackenzie Financial Corp bought a new position in shares of Encompass Health in the third quarter valued at approximately $223,000. Nordea Investment Management AB lifted its holdings in Encompass Health by 13.6% during the third quarter. Nordea Investment Management AB now owns 57,325 shares of the company’s stock worth $4,468,000 after acquiring an additional 6,856 shares during the period. AQR Capital Management LLC lifted its holdings in Encompass Health by 177.2% during the third quarter. AQR Capital Management LLC now owns 70,264 shares of the company’s stock worth $5,477,000 after acquiring an additional 44,915 shares during the period. Morgan Stanley lifted its holdings in Encompass Health by 25.8% during the third quarter. Morgan Stanley now owns 638,008 shares of the company’s stock worth $49,731,000 after acquiring an additional 130,728 shares during the period. Finally, Bank of New York Mellon Corp lifted its holdings in Encompass Health by 1.5% during the third quarter. Bank of New York Mellon Corp now owns 1,433,372 shares of the company’s stock worth $111,731,000 after acquiring an additional 21,766 shares during the period. Institutional investors own 93.18% of the company’s stock.
In other news, CEO Mark J. Tarr sold 67,382 shares of the firm’s stock in a transaction that occurred on Wednesday, May 1st. The stock was sold at an average price of $63.56, for a total value of $4,282,799.92. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Leo I. Higdon, Jr. bought 1,000 shares of the company’s stock in a transaction dated Thursday, March 7th. The stock was bought at an average price of $58.84 per share, for a total transaction of $58,840.00. The disclosure for this purchase can be found here. 1.60% of the stock is owned by company insiders.
The business also recently announced a quarterly dividend, which will be paid on Monday, July 15th. Stockholders of record on Monday, July 1st will be issued a $0.27 dividend. The ex-dividend date is Friday, June 28th. This represents a $1.08 dividend on an annualized basis and a dividend yield of ∞.
Encompass Health Company Profile
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.